tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences

Need an answer now?

Give us a call

Leave a message, we'll get back to you

Antibodies for cancer research, validated by NCI

Rockland Immunochemicals, partnering with the National Cancer Institute’s Center for Cancer Research, has released 95 antibodies that are involved in signal transduction and cancer research. The goal of this collaboration is to combine basic and applied research principles, working with life science researchers to develop better bioreagents that will facilitate biomedical research. These reagents assist in the understanding of cell function as it relates to cancer management.


These antibodies, which are involved in signal transduction and cancer research, were developed in conjunction with the NCI’s Center for Cancer Research (CCR):